The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | AH Bio Fund IV, L.P. owner | CConversion Series A Preferred Stockderivativeindirect: By AH Bio Fund IV, L.P. | -40,000,000 | $0.00 | $0 | 0 | Aug 11, 2026 |
| Aug 7, 2026 | LB LandBridge Co LLC | LandBridge Holdings LLC director, owner | CConversion Class A shares | +1,250,000 | $0.00 | $0 | 1,250,000 | Aug 11, 2026 |
| Aug 7, 2026 | LB LandBridge Co LLC | LandBridge Holdings LLC director, owner | CConversion DBR Land Holdings LLC Unitsderivative | -1,250,000 | $0.00 | $0 | 47,168,908 | Aug 11, 2026 |
| Aug 7, 2026 | LB LandBridge Co LLC | David N Capobianco director, owner | CConversion Class A sharesindirect: See Footnote | +1,250,000 | $0.00 | $0 | 1,250,000 | Aug 11, 2026 |
| Aug 7, 2026 | LB LandBridge Co LLC | David N Capobianco director, owner | CConversion DBR Land Holdings LLC Unitsderivativeindirect: See Footnote | -1,250,000 | $0.00 | $0 | 47,168,908 | Aug 11, 2026 |
| Aug 7, 2026 | GOOGL Alphabet Inc. | Brin Sergey director, owner | CConversion Class A Common Stock | +673,200 | $0.00 | $0 | 710,669 | Aug 11, 2026 |
| Aug 7, 2026 | GOOGL Alphabet Inc. | Brin Sergey director, owner | CConversion Class B Common Stockderivative | -673,200 | $0.00 | $0 | 357,921,378 | Aug 11, 2026 |
| Aug 7, 2026 | ABNB Airbnb, Inc. | Brian Chesky CEO and Chairman | CConversion Class A Common Stockindirect: By 2016 Legacy Trust B10b5-1 | +20,000 | - | - | 25,854 | Aug 11, 2026 |
| Aug 7, 2026 | ABNB Airbnb, Inc. | Brian Chesky CEO and Chairman | CConversion Class B Common Stockderivativeindirect: By 2016 Legacy Trust B10b5-1 | -20,000 | $0.00 | $0 | 136,131 | Aug 11, 2026 |
| Aug 7, 2026 | ABNB Airbnb, Inc. | Nathan Blecharczyk Chief Strategy Officer | CConversion Class A Common Stockindirect: By Trust10b5-1 | +690,000 | - | - | 702,370 | Aug 11, 2026 |
| Aug 7, 2026 | ABNB Airbnb, Inc. | Nathan Blecharczyk Chief Strategy Officer | CConversion Class B Common Stockderivativeindirect: By Trust10b5-1 | -690,000 | $0.00 | $0 | 45,027,201 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Diego Ezequiel Apalategui Director of Sales & Operations | CConversion Class A Common Shares | +266,664 | - | - | 383,664 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Diego Ezequiel Apalategui Director of Sales & Operations | CConversion Class C Common Sharesderivative | -266,664 | - | - | 0 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Sami Gabriel Khouri director | CConversion Class A Common Sharesindirect: By MNCF Ltd. | +3,369,648 | - | - | 3,369,648 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Sami Gabriel Khouri director | CConversion Class C Common Sharesderivativeindirect: By MNCF Ltd. | -3,369,648 | - | - | 0 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Espinosa Eduardo Pizzuto Chief Financial Officer | CConversion Class A Common Shares | +830,714 | - | - | 1,005,714 | Aug 11, 2026 |
| Aug 7, 2026 | TBBB BBB FOODS INC | Espinosa Eduardo Pizzuto Chief Financial Officer | CConversion Class C Common Sharesderivative | -830,714 | - | - | 0 | Aug 11, 2026 |
| Aug 7, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class A Common Stockindirect: By: Index Ventures Growth III (Jersey) L.P. | +1,511,093 | - | - | 1,826,508 | Aug 11, 2026 |
| Aug 7, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class A Common Stockindirect: By: Yucca (Jersey) SLP | +23,011 | - | - | 27,814 | Aug 11, 2026 |
| Aug 10, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class A Common Stockindirect: By: Index Ventures Growth III (Jersey) L.P. | +34,181 | - | - | 34,181 | Aug 11, 2026 |
| Aug 10, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class A Common Stockindirect: By: Yucca (Jersey) SLP | +520 | - | - | 520 | Aug 11, 2026 |
| Aug 7, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class B Common Stockderivativeindirect: By: Index Ventures Growth III (Jersey) L.P. | -1,511,093 | $0.00 | $0 | 35,831,901 | Aug 11, 2026 |
| Aug 7, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class B Common Stockderivativeindirect: By: Yucca (Jersey) SLP | -23,011 | $0.00 | $0 | 545,643 | Aug 11, 2026 |
| Aug 10, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class B Common Stockderivativeindirect: By: Index Ventures Growth III (Jersey) L.P. | -34,181 | $0.00 | $0 | 35,797,720 | Aug 11, 2026 |
| Aug 10, 2026 | AUR Aurora Innovation, Inc. | Michelangelo Volpi director | CConversion Class B Common Stockderivativeindirect: By: Yucca (Jersey) SLP | -520 | $0.00 | $0 | 545,123 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +938,979 | - | - | 1,368,532 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +3,547,842 | - | - | 4,916,374 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +1,027,635 | - | - | 5,944,009 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +3,464,072 | - | - | 3,510,927 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +1,484,401 | - | - | 4,995,328 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +165,519 | - | - | 5,160,847 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Common Stockindirect: See footnote | +2,066,857 | - | - | 2,094,813 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series Seed Convertible Preferred Stockderivativeindirect: See footnote | -938,979 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series A Convertible Preferred Stockderivativeindirect: See footnote | -3,547,842 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series A-2 Convertible Preferred Stockderivativeindirect: See footnote | -1,027,635 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series A-2 Convertible Preferred Stockderivativeindirect: See footnote | -3,464,072 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series B Convertible Preferred Stockderivativeindirect: See footnote | -1,484,401 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Series A-2 Convertible Preferred Stockderivativeindirect: See footnote | -2,066,857 | - | - | 0 | Aug 11, 2026 |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Westlake BioPartners Fund I, L.P. owner | CConversion Convertible Promissory Notederivativeindirect: See footnote | -165,519 | - | - | 0 | Aug 11, 2026 |
| Aug 4, 2026 | DLO dLocal Ltd | Sebastian Kanovich director | CConversion Class A Common Share10b5-1 | +4,700 | - | - | 4,700 | Aug 11, 2026 |
| Aug 5, 2026 | DLO dLocal Ltd | Sebastian Kanovich director | CConversion Class A Common Share10b5-1 | +72,753 | - | - | 72,753 | Aug 11, 2026 |
| Aug 4, 2026 | DLO dLocal Ltd | Sebastian Kanovich director | CConversion Class B Common Sharederivative10b5-1 | -4,700 | $0.00 | $0 | 11,599,074 | Aug 11, 2026 |
| Aug 5, 2026 | DLO dLocal Ltd | Sebastian Kanovich director | CConversion Class B Common Sharederivative10b5-1 | -72,753 | $0.00 | $0 | 11,526,321 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Erez Chimovits director, owner | CConversion Common Stockindirect: See footnotes | +9,132,420 | - | - | 10,235,159 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Erez Chimovits director, owner | CConversion Series A Preferred Stockderivativeindirect: See footnotes | -40,000,000 | $0.00 | $0 | 0 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Orbimed Advisors LLC director, owner | CConversion Common Stockindirect: See footnotes | +9,132,420 | - | - | 10,235,159 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Orbimed Advisors LLC director, owner | CConversion Series A Preferred Stockderivativeindirect: See footnotes | -40,000,000 | $0.00 | $0 | 0 | Aug 11, 2026 |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Vincent Paul Liptak General Counsel | CConversion Common Stockindirect: By Walter T. Liptak Revocable Trust | +22,687 | - | - | 22,687 | Aug 10, 2026 |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Vincent Paul Liptak General Counsel | CConversion Series B Preferred Stockderivativeindirect: By Walter T. Liptak Revocable Trust | -22,687 | - | - | 0 | Aug 10, 2026 |
| Aug 6, 2026 | CHYM Chime Financial, Inc. | Christopher R Britt Chief Executive Officer | CConversion Class A Common Stockindirect: See footnote10b5-1 | +200,000 | $0.00 | $0 | 200,000 | Aug 10, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.